Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Malaria Initiative to Use Exxon Grant to Study Genomics of Malaria-causing Organism

This article mistakenly reported that Exxon Mobil has funded the Harvard Malaria Initiative to sequence the genome of Plasmodium falciparum. In fact, the genome was sequenced in 2002, and the Exxon grant will help Harvard researchers study the mechanisms and genomics of the organism.

 

NEW YORK, Jan. 28 (GenomeWeb News) - Researchers at the Harvard Malaria Initiative will use part of a $5 million grant from Exxon Mobil to research the mechanisms and genomics of Plasmodium falciparum, the oil giant said today.

 

Harvard researchers will use the money to identify novel drug targets and train African scientists in anti-malarial drug techniques. The program, which did not disclose Harvard's award, is part of 24 awards Exxon Mobil has issued to help fight malaria in Africa, the company said.

 

"Through our African Health Inititative, we are working to support governments and health care providers to reduce the impact of this devastating disease," Rex Tillerson, president of Exxon Mobil, said in a statement.

 

The genome of P. falciparum, the most deadly malaria parasite, was sequenced in 2002 by the Institute for Genomic Research, Sanger, and Stanford.

 

Other initiative grants focused on community education, volunteer training, bednet distribution, medical supplies, marketing of long-lasting insecticide, scientific training and sanitation. Exxon Mobil is awarding the money because it has "major oil and gas production operations" in five African nations. The company also has retail, marketing, and distribution "activities" in more than 20 nations on the continent.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.